trophoresis after photolysis indicates that primarily the 13 polypeptide chain is appreciably labeled (86%), although some labeling of the a polypeptide chain is found (14%). For the site that binds MgATP tightly, 97% of the radioactivity is found on the ( polypeptide chain. The a and (3 polypeptide chains are labeled in approximately equal amounts when photolysis is carried out with the nucleotide analog bound to the third site.
The dicyclohexylcarbodiimide-sensitive ATPase of chloroplast thylakoid membranes is the final enzyme in oxidative phosphorylation and is responsible for the synthesis of ATP (cf. ref. 1 ). Chloroplast coupling factor 1 (CF1) is the watersoluble portion of this complex and possesses a latent ATPase activity specific for Ca2+ (2) . CF1 has five different types of polypeptide chains (a, (3, y, 8 , and E); recent reports suggest a subunit stoichiometry of a3(33y8E (3) .
Solubilized CF1 possesses nucleotide binding sites that function in both catalysis and its regulation (4, 5) . Thus far, three specific sites have been identified, each exhibiting distinct characteristics. A single site, whose function is controversial, binds ADP very tightly (site 1; see refs. [6] [7] [8] . ADP or ATP can exchange into this site, but only ADP is found bound to the enzyme; when trinitrophenyl-ADP binds to this site, hydrolytic activity is abolished. A second site binds MgATP very tightly (site 2). Whether or not this site is occupied does not affect the catalytic activity of the enzyme, although its role may be regulatory on membrane-bound CF1 (8) . The third site binds either ADP or ATP with a dissociation constant in the micromolar range (site 3), and it is a likely candidate for a catalytic site (8) .
Photoactivatable nucleotide analogs have been used extensively to determine the polypeptide chain location of each of these sites. By inserting covalently into selected regions on the enzyme, these compounds have been invaluable as site-specific labels (9) . Experiments with 3'-O-[3-N-(4-azido-2-nitrophenyl)aminopropionyl]-ADP and -ATP have shown that primarily the 8 polypeptide chain is labeled after photolysis of this analog when bound to the site to which MgATP binds tightly and that the a and 3polypeptides are labeled in approximately equal amounts when the label is bound to site 3 (7) . Thus far, photoaffinity labeling of the site normally occupied by ADP has not been possible. Recently, however, photoreactive labeling with 2-azidoadenosine diphosphate bound to membrane-bound CF1 at a site normally containing ADP has resulted in labeling of the 3 polypeptide (10) . A similar experiment with 3'-O-(4-benzoyl)benzoyl-ADP resulted in the labeling of both the a and 83 polypeptide chains (11) .
In this investigation, the interactions of the photoaffinity label 3'-0-(4-benzoyl)benzoyl-ATP (BzATP) with soluble CF1 were studied. This substrate analog is an effective inhibitor of ATPase activity, as well as a derivative capable of binding to each nucleotide site. Studies using radioactive BzATP as a site-specific photoaffinity label on soluble CF1 have permitted the isolation of labeled polypeptides associated with binding at each of the three nucleotide sites. For the site that binds both ADP and ATP reversibly, the a and f3 polypeptides again were labeled in approximately equal amounts; for the other two sites, predominantly the 3 polypeptide was labeled.
MATERIALS AND METHODS Chemicals. ATP, 1,1'-carbonyldiimidazole, and Tris were from Sigma; 4-benzoylbenzoic acid was from Aldrich; [2,3- 3H]ATP (ammonium salt) with a specific activity of 32 Ci/ mmol (1 Ci = 37 GBq) was purchased from Amersham. All other reagents used were high quality commercial grades, and all solutions were prepared with distilled deionized water.
Enzyme. CF1 was prepared from fresh market spinach following procedures slightly modified from Lien and Racker (12) and Binder et al. (13) . Purified enzyme was stored as an ammonium sulfate precipitate in saturated ammonium sulfate, 20 mM Tris S04/2 mM EDTA, pH 7.1, and kept at 40C for no longer than 1 month. Assays for enzymatic activity were performed periodically by heat-activating a solution (1-2 mg/ml) of latent solubilized CF1 for 5.0 min at 640C in the presence of 40 mM ATP/10 mM dithiothreitol/2 mM EDTA/40 mM Tris-HCl, pH 8.0 (3). The activity was typically [15] [16] [17] [18] [19] [20] ttmol/(mg min). For the purified latent enzyme, both free and dissociable nucleotides were removed prior to all experiments by passage through two consecutive 3-ml centrifuge columns containing Sephadex G-50 pre-equilibrated with appropriate buffer (14) . An extinction coefficient of 0.483 cm2-mg-l (277 nm) was used to determine all enzyme concentrations (7) .
Synthesis of BzATP. BzATP was prepared following the procedure of Williams and Coleman (15) with only minor modifications. Under an atmosphere of dry nitrogen, 4-benzoyl benzoic acid (final concentration, 0.14 M) and 1,1'-carbonyldiimidazole (final concentration, 0.43 M) were dissolved in 5.0 ml of distilled anhydrous dimethylformamide and stirred for 15 min at room temperature. After the initial reaction, 25 ml of an aqueous ATP solution (final concentration, 0.03 M) was added to the medium, and the synthetic reaction was allowed to proceed for 19 hr in the dark. SolAbbreviations: CFj, chloroplast coupling factor 1; BzATP, 3'-0-(4-benzoyl)benzoyl-ATP.
1950
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. [2,8-3H ]ATP from site 1, and MgBzATP was found to bind tightly to site 2, analogously to MgATP (7) . Subsequent denaturation of the enzyme followed by NaDodSO4/polyacrylamide gel electrophoresis resulted in the separation of all five polypeptide chains. Each chain was then analyzed for incorporation of radioactivity to determine the specific location of each nucleotide binding site. The a and f8 chains were completely resolved: an unstained area of gel separated the Coomassie blue-stained bands associated with the a and 13 polypeptide chains.
Earlier work using photoactivatable aryl-azido derivatives of ADP and ATP proved unsuccessful in identifying the subunit location of site 1 on latent purified CF1 (7). With BzATP as a new photoactivatable ligand, however, specific labeling of the A polypeptide occurred (Table 1 ; Fig. 1 Percentage of total radioactivity for a and ,B polypeptides was obtained from 3 x 10 mm (diameter) sections of polyacrylamide geld (Fig. 1 Incubation of [2,8-3H ]BzATP with latent CF1 in the presence of Mg2+ for 1 min followed by gel filtration to remove excess nucleotide, photoactivation, and electrophoresis revealed that >95% of all radioactivity incorporated into the gel was located on the 3 polypeptide (Table 1 ; Fig. 1 ). To ensure that label was not present in site 1 at the time of photolysis, a second experiment was performed prior to photolysis, in which labeled enzyme was freed from excess nucleotide and Mg2' and then incubated an additional 8 hr in excess ATP. The same results were obtained in both cases and correlate well with earlier studies that identified the (B polypeptide as being labeled when site 2 contains the photoaffinity label (7) .
Because of the relatively high dissociation constant associated with nucleotides binding at site 3, separation of free nucleotide before photolysis was not possible, and photoactivation of the BzATP analog had to be carried out in situ. After blocking site 2 with MgATP, an equivalent concentration of [2,8-3H] BzATP was added to a solution of CF1 that was photolyzed immediately. Removal of free nucleotide label yielded a stoichiometry of 0.25 mol of label per mol of CF1, indicating the inherent difficulty in attempting to label site 3 efficiently. However, specificity of labeling was attained by using a concentration of [2,8-3H] BzATP that was equivalent to or only in slight excess of the enzyme concentration. Table 1 and Fig. 1 give the results obtained after electrophoretic analysis and indicate that a and , polypeptides are labeled nearly equivalently when BzATP is targeted for site 3.
Further confirmation of the previous results indicating that both sites 1 and 2 reside primarily on the , polypeptide of latent CF1 was obtained by labeling both sites 1 and 2 together. Table 1 shows that when CF1 is incubated with [2,8-3H] BzATP in the presence of Mg2' and then photoactivated after removal of free nucleotide from the medium, the label/enzyme stoichiometry increases to 2.08, indicating that both sites have been labeled with analog. When the labeled CF1 subunits are then separated on polyacrylamide gels, 95% of all bound label is found to comigrate with the (3 polypeptide.
DISCUSSION
The use of BzATP as a photoactivatable nucleotide analog has proven to be successful in the site-specific labeling of each of three nucleotide binding sites present on purified solubilized CF1. Although covalent incorporation of label is not an efficient process, its utility as a covalently inserting analog should not be underestimated. (The stoichiometries for sites 1 and 2 in Table 1 are not a measure of covalent incorporation because the nucleotides are tightly bound prior to photolysis.) In particular, BzATP possesses some unique advantages over many of the azido nucleotides that have been used in previous studies with CF1. Apart from its stability over the pH 4-10 range, BzATP is virtually nonreactive with water and appears to exhibit a very selective covalent insertion pattern (15) . Williams and Coleman (15) have postulated a probable mechanism of reaction consistent with their own results using BzATP on mitochondrial coupling factor 1. According to their interpretation, photolysis stimulates excitation of the carbonyl group in the benzophenone moiety to form a highly reactive diradical triplet. Radical oxygen then abstracts a hydrogen atom from nearby methylene residues present in the enzyme, resulting in a transient caged radical pair, which quickly degenerates to form a carbon-carbon covalent bond between substrate and enzyme. The formation of a carbon-carbon single bond is a major advantage over less stable bonds with nitrogen formed from the more commonlv used nitrene intermediates.
In the results presented here, BzATP has been shown to function first as an effective inhibitor of CF1 ATPase activity, and second as a ligand that can be induced to covalently insert into any one or all of the desired binding sites on the enzyme. The inhibition observed appears to be similar to that found with the trinitrophenyl derivatives of ADP and ATP (8) .
Prior to the investigation reported here, attempts to identify the subunit location of the site on soluble CF1 containing tightly bound ADP had failed. Earlier studies using arylazido derivatives of ADP and ATP resulted in the location of the MgATP at a site on or near the (3polypeptide, and site 3 near an interface between both a and f8 subunits (7) . Recently, the location of a site on membrane-bound CF1 containing tightly bound ADP has been identified as the P polypeptide with 2-azidoadenosine diphosphate as the label (10) and as both the a and , polypeptides with BzATP as the label (11) . In our experiments, however, use of the BzATP substrate analog has resulted in the labeling of all three well-characterized nucleotide binding sites on soluble purified CF1. Analysis of the data obtained after electrophoresis of the labeled denatured enzyme confirms previous results, with a different nucleotide analog, that binding of the analog at site 2 results predominantly in labeling of the , polypeptide (97%) and binding at site 3 results in equal labeling of a and , polypeptides. In addition, binding at site 1 results predominantly in labeling of the 3polypeptide (86%) on soluble CF1, although some labeled a polypeptide is consistently labeled.
The simplest interpretation of these results is that all three nucleotide sites are located in a similar region of the enzyme. However, conformational differences result in different labeling patterns. The extreme case is site 3, where one-half of the radioactivity is found on the a polypeptide. Thus, all three nucleotide sites are probably near the interface of the a and 83polypeptides, although predominantly on the 3poly-Proc. NatL Acad Sci. USA 82 (1985) peptide. Whether the conformational differences are due to preexisting asymmetry in the structure of the enzyme or to ligand-induced asymmetry is not known. A similar dilemma exists in considering whether the mechanism of the enzyme involves alternating activity of equivalent nucleotide binding sites (cf. refs. 16 and 17) or a structural asymmetry in the function of the nucleotide binding sites that is retained during the catalytic cycle (cf. refs. 8 and 18) .
The next step in defining the location of the nucleotide binding sites is to purify the individual radioactive peptides and to carry out amino acid analyses and protein sequencing.
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